Affirm CFO Exercises Options; Sells 25,533 Shares at $90.71 Avg
Rhea-AI Filing Summary
Jiyane Siphelele, Chief Accounting Officer of Affirm Holdings, Inc. (AFRM), reported option exercises and a subsequent sale on 09/04/2025. The Form 4 shows the exercise of a stock option with a $1.68 exercise price for 14,367 shares and a stock option with a $5.39 exercise price for 11,166 shares. Those exercises increased the reported holdings to 252,000 shares before a sale of 25,533 Class A common shares at a weighted average price of $90.71, leaving 226,467 shares beneficially owned after the transactions. The filing includes an explanatory footnote that the $90.71 price is a weighted average of sales from $90.62 to $90.83. The Form 4 was signed by attorney-in-fact Josh Samples on 09/08/2025.
Positive
- Transparent disclosure of option exercises, sale, and resulting beneficial ownership, including weighted average sale price range
- Detailed footnote clarifies weighted average sale price and vesting schedule for the $5.39 option
Negative
- Insider sale of 25,533 shares reduces reported holdings from 252,000 to 226,467 shares
- No information in the filing about the purpose of the sale or use of proceeds
Insights
TL;DR: Routine insider option exercises followed by an open-market sale; material only to ownership statistics.
The Form 4 documents the exercise of two option tranches and an immediate or contemporaneous sale of the combined exercised shares. The reporting shows 14,367 shares exercised at $1.68 and 11,166 shares exercised at $5.39, then a sale of 25,533 shares at a weighted average of $90.71, resulting in 226,467 shares owned after the transactions. This is a standard securities disclosure that updates insider beneficial ownership; it contains no new financial results or operational changes.
TL;DR: Disclosure complies with Section 16 reporting by identifying exercise, sale, and post-transaction ownership.
The filing identifies the reporting person, relationship to the issuer (Chief Accounting Officer), transaction dates, prices, and quantities, meeting Form 4 content requirements. The explanatory footnotes clarify the weighted average sale price and vesting schedule of the $5.39 option. The signature by an attorney-in-fact is included. There are no governance actions, departures, grants beyond exercised options, or other corporate governance events disclosed.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 14,367 | $0.00 | -- |
| Exercise | Stock Option (Right to Buy) | 11,166 | $0.00 | -- |
| Exercise | Class A Common Stock | 14,367 | $1.68 | $24K |
| Exercise | Class A Common Stock | 11,166 | $5.39 | $60K |
| Sale | Class A Common Stock | 25,533 | $90.71 | $2.32M |
Footnotes (1)
- Represents the weighted average sale price of the shares sold from $90.62 to $90.83 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The stock option vested with respect to the shares of Class A Common Stock underlying the stock option in equal monthly installments for a period of forty-eight months beginning on November 1, 2017, subject to the Reporting Person's continued employment with the Issuer as of each vesting date.
